Claire M Bewshea

17PUBLICATIONS
78CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyImmunogenetics (incl. genetic immunology)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 13, 2025
Understanding Anti-TNF Treatment Failure: Pre-Existing Antidrug Antibodies Are Common but Do Not Neutralize Drug Activity In Vitro or Influence Clinical Response to Infliximab or Adalimumab in Patients with Crohn Disease.

Rachel Nice, Simeng Lin, Neil Chanchlani

|Jun 23, 2025
Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource.

Christopher Roberts, Jaime Peters, Aleksejs Sazonvos

|Nov 09, 2023
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib.

Zhigang Liu, James L Alexander, Kai Yee Eng

|Sep 30, 2023
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients.

Benjamin Y H Bai, Mark Reppell, Nizar Smaoui

|Aug 08, 2023
Whole Blood DNA Methylation Changes Are Associated with Anti-TNF Drug Concentration in Patients with Crohn's Disease.

Simeng Lin, Eilis Hannon, Mark Reppell

|Jun 28, 2023
Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn's Disease.

Maja Hanić, Frano Vučković, Helena Deriš

Pageof 3

Frequent Collaborators

17 joint publications

Tariq Ahmad

15 joint publications

Neil Chanchlani

14 joint publications

James R Goodhand

13 joint publications

Simeng Lin